Menu
The CCS Investment Program helps connect innovators creating human-relevant research technologies that can replace animal testing with potential investors.
The CCS Investor Summit is one-of-a-kind business development event. It brings together innovators, investors, researchers, and venture philanthropists to support new technologies and bolster investments in the emerging field of human-relevant alternatives to animal experimentation. The summit, like other activities at CCS, facilitates the cross-pollination of ideas, provides much needed exposure to business entities, and unlocks entrepreneurial potential under expert feedback.
Lung on a Chip*
Credit: Wyss Institute
In 2022, CCS, in partnership with Beyond Animal, held the world’s first Summit to replace animal testing geared for investors. It brought together innovators, researchers, start-ups, and venture philanthropists from around the world. The event educated investors about human-relevant testing methods and introduced them to international companies creating testing methods that can replace animal experiments.
CCS has formed a partnership with the GlassWall Syndicate (GWS). GWS is a large group of venture capitalists, individual investors, foundations, and trusts to establish a collaborative venue to bring together investors interested in human-specific testing methods with the companies creating these methods.
Criteria:
CCS is a nonprofit 501(c)(3) organization. Contributions to CCS are tax deductible to the extent permitted by law. EIN 84-3817744